Judge Orders United Therapeutics to Pay Sandoz $137 Million in Generic Drug Dispute

United Therapeutics Corp. has been ordered to pay Sandoz Inc. $137.2 million for breaching a previous settlement agreement and obstructing the sale of Sandoz’s generic injectable drug for treating hypertension. This decision was handed down by a federal judge in New Jersey. Further details on the case can be found in the report by Law360.